![](https://cdn04.allafrica.com/download/pic/main/main/csiid/00611097:feb1706724376b3d9b7cebd501e31e9e:arc614x376:w1200.jpg)
'New HIV Drug Offers Hope of Ending AIDS, But Access is Key'
The Joint United Nations Programme on HIV/AIDS (UNAIDS) has praised the release of trial results for Gilead Sciences' new injectable long-acting HIV medicine, Lenacapavir, for Pre-Exposure Prevention (PrEP). The trial, conducted among cis-gender …